Pharm Test Part 12

Front 1

Treatment for schizophrenia has three goals: suppression of acute episodes, prevention of acute exacerbations, and maintenance of the highest possible level of functioning, and maintenance, of the highest possible level of functioning.

Back 1

Haloperidol (High Potency)

Front 2

Therapeutic Goals: Principle indications are schizophrenia and other psychotic disorders. Additional psychiatric indications are schizoaffective disorder and the manic phase of bipolar disorder. Other uses include suppression of emesis and relief of intractable hiccups.

Back 2

Chlorpromazine (Low Potency)

Front 3

Therapeutic Goals: Alleviation of symptoms of major depression.

Back 3

Tricyclic

Front 4

Therapeutic Goals: Alleviation of symptoms of major depression, especially atypical depression.

Back 4

Monoamine Oxidase Inhibitors

Front 5

Therapeutic Goals: Control of acute manic episodes in patients with BPD, and prophylaxis against recurrent mania and depression in patients with BPD.

Back 5

Lithium

Front 6

Benzodiazepines are used to promote sleep, relieve symptoms of anxiety, suppress seizure disorders, relax muscle spasm, and ease withdrawal from alcohol. They are also used for preanesthetic medication and to induce general anesthesia.

Back 6

Diazepam

Front 7

Therapeutic Goals: Alleviation of symptoms of major depression. All SSRIs except fluvoxamine are approved for treating depression.

Back 7

Fluoxetine

Front 8

1. Seizure Disorder
2. Induction of Anesthesia
3. Insomnia
4. Barbiturates have been used to treat acute manic states and delirium.

Back 8

Phenobarbital

Front 9

Therapeutic Goals: Reduction of symptoms in children and adults with ADHD. Reduction of sleep attacks in patients with narcolepsy.

Back 9

Methylphenidate